AIML Announces Closing of Oversubscribed Private Placement
AI/ML Innovations (AIMLF) has successfully completed an oversubscribed non-brokered private placement, raising $2,165,900 by issuing 43,318,000 units at $0.05 per unit. Each unit includes one common share and one warrant exercisable at $0.15 until April 15, 2028.
The company paid $101,815 in finder's fees and issued 1,917,300 finder's warrants. Company insiders participated significantly, with CEO Paul Duffy acquiring 4,250,000 units and President Peter Kendall purchasing 3,000,000 units. The proceeds will be used for general working capital.
Additionally, AIMLF modified terms for existing warrants from June 2023, simplifying the previous escalating exercise price structure to a fixed $0.20 exercise price for both 14,827,792 share purchase warrants and 411,800 broker warrants.
AI/ML Innovations (AIMLF) ha completato con successo un collocamento privato non intermediato e sovrasottoscritto, raccogliendo 2.165.900$ emettendo 43.318.000 unità a 0,05$ ciascuna. Ogni unità comprende un'azione ordinaria e una warrant esercitabile a 0,15$ fino al 15 aprile 2028.
La società ha pagato 101.815$ in commissioni ai procacciatori e ha emesso 1.917.300 warrant ai procacciatori. Gli insider dell’azienda hanno partecipato in modo significativo, con il CEO Paul Duffy che ha acquisito 4.250.000 unità e il Presidente Peter Kendall che ne ha acquistate 3.000.000. I proventi saranno utilizzati per il capitale circolante generale.
Inoltre, AIMLF ha modificato le condizioni delle warrant esistenti da giugno 2023, semplificando la precedente struttura di prezzo di esercizio crescente a un prezzo fisso di 0,20$ per entrambe le 14.827.792 warrant per l’acquisto di azioni e le 411.800 warrant dei broker.
AI/ML Innovations (AIMLF) ha completado con éxito una colocación privada no intermediada y sobresuscrita, recaudando 2.165.900$ mediante la emisión de 43.318.000 unidades a 0,05$ por unidad. Cada unidad incluye una acción común y una opción de compra ejercitable a 0,15$ hasta el 15 de abril de 2028.
La empresa pagó 101.815$ en comisiones a intermediarios y emitió 1.917.300 opciones para intermediarios. Los directivos de la compañía participaron significativamente, con el CEO Paul Duffy adquiriendo 4.250.000 unidades y el presidente Peter Kendall comprando 3.000.000. Los fondos se destinarán a capital de trabajo general.
Además, AIMLF modificó los términos de las opciones existentes desde junio de 2023, simplificando la anterior estructura de precio de ejercicio escalonado a un precio fijo de 0,20$ para las 14.827.792 opciones de compra de acciones y las 411.800 opciones de los intermediarios.
AI/ML Innovations (AIMLF)는 중개인 없이 진행된 과잉 청약 사모 발행을 성공적으로 완료하여, 단위당 0.05달러에 43,318,000 단위를 발행해 2,165,900달러를 조달했습니다. 각 단위는 보통주 1주와 2028년 4월 15일까지 행사 가능한 행사가 0.15달러의 워런트 1개로 구성됩니다.
회사는 중개인 수수료로 101,815달러를 지급하고 1,917,300개의 중개인 워런트를 발행했습니다. 경영진도 적극 참여했으며, CEO 폴 더피는 4,250,000 단위를, 사장 피터 켄달은 3,000,000 단위를 매입했습니다. 조달된 자금은 일반 운전자본으로 사용될 예정입니다.
또한 AIMLF는 2023년 6월부터 기존 워런트 조건을 수정하여, 이전의 점진적 행사 가격 구조를 단순화하고 14,827,792주 주식 매수 워런트와 411,800개의 중개인 워런트 모두에 대해 고정 행사 가격 0.20달러로 변경했습니다.
AI/ML Innovations (AIMLF) a réussi une émission privée non-intermédiée sursouscrite, levant 2 165 900 $ en émettant 43 318 000 unités à 0,05 $ chacune. Chaque unité comprend une action ordinaire et un bon de souscription exerçable à 0,15 $ jusqu'au 15 avril 2028.
La société a versé 101 815 $ de frais d'intermédiaire et émis 1 917 300 bons de souscription pour les apporteurs d'affaires. Les dirigeants de l’entreprise ont largement participé, le PDG Paul Duffy ayant acquis 4 250 000 unités et le président Peter Kendall 3 000 000 unités. Les fonds seront utilisés pour le fonds de roulement général.
De plus, AIMLF a modifié les conditions des bons de souscription existants datant de juin 2023, simplifiant la structure de prix d’exercice progressive précédente en un prix fixe de 0,20 $ pour les 14 827 792 bons d’achat d’actions et les 411 800 bons des courtiers.
AI/ML Innovations (AIMLF) hat eine überzeichnete, nicht vermittelte Privatplatzierung erfolgreich abgeschlossen und dabei 2.165.900$ durch die Ausgabe von 43.318.000 Einheiten zu je 0,05$ eingenommen. Jede Einheit umfasst eine Stammaktie und einen Warrant, der bis zum 15. April 2028 zu 0,15$ ausgeübt werden kann.
Das Unternehmen zahlte 101.815$ an Vermittlungsgebühren und gab 1.917.300 Vermittler-Warrants aus. Unternehmensinterne Beteiligte nahmen bedeutend teil, wobei CEO Paul Duffy 4.250.000 Einheiten und Präsident Peter Kendall 3.000.000 Einheiten erwarben. Die Erlöse werden für das allgemeine Betriebskapital verwendet.
Zusätzlich hat AIMLF die Bedingungen bestehender Warrants aus Juni 2023 angepasst und die zuvor gestaffelte Ausübungspreisstruktur auf einen festen Ausübungspreis von 0,20$ für sowohl 14.827.792 Aktienkauf-Warrants als auch 411.800 Vermittler-Warrants vereinfacht.
- Raised $2.17M through oversubscribed private placement, exceeding initial $2M target
- Strong insider participation with management purchasing 7.25M units
- Simplified warrant structure may encourage exercise of June 2023 warrants
- Significant dilution with 43.3M new units issued
- Low unit price of $0.05 indicates weak share price
- Additional dilution potential from 45.2M total warrants outstanding
VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously announced non-brokered private placement offering on April 15, 2025 on an oversubscribed basis.
On April 7, 2025, the Company announced a proposed private placement of up to 40,000,000 units ("Units") at a price of
Each Unit is comprised of one Common Share and one warrant which will be exercisable into one (1) Common Share of the Company (each a "Warrant"). Each Warrant entitles the holder threof to acquire one (1) additional Common Share at an exercise price of
The net proceeds from the Private Placement are expected to be used for general working capital. All securities issued pursuant to the Private Placement will be subject to a statutory hold period ending August 16, 2025.
In connection with the Private Placement, aggregate finder's fees of
Paul Duffy, CEO and Executive Chairman, comments "We are extremely grateful for the confidence and support shown by our investors in this oversubscribed financing. Their participation is a strong vote of confidence in our vision and strategic direction. These funds will help accelerate our mission to bring AI and machine learning innovations to the healthcare space and create long-term value for all stakeholders."
Insider Participation
Mr. Paul Duffy (through a company owned and controlled by him), the Company's CEO, and Mr. Peter Kendall (through a company owned and controlled by him), the Company's President, (together, the "Insiders") each participated in the Private Placement by acquiring 4,250,000 Units in the case of Mr. Duffy and 3,000,000 Units in the case of Mr. Kendall. As a result of the participation of the Insiders in the Private Placement, the Private Placement constitutes a "related party transaction" under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101").
Pursuant to sections 5.5(a) and 5.7(1)(a) of MI 61-101, the Company is exempt from obtaining a formal valuation and minority approval of the Company's shareholders as the fair market value of each of the Insider's participation, individually, and in aggregate, in the Private Placement is below
A material change report including details with respect to the related party transaction could not be filed less than 21 days prior to the closing of the Private Placement as the Company did not receive prior confirmation of such participation and the Company deemed it reasonable in the circumstances so as to be able to avail itself of potential financing opportunities and complete the Private Placement in an expeditious manner.
June 2023 Financing - Warrant Acceleration Clause Update
The Company also announces that it has modified the terms of an aggregate of 14,827,792 existing share purchase warrants (the "2023 Warrants") and 411,800 broker warrants (the "2023 Broker Warrants") which were issued in two tranches on June 8, 2023 and July 4, 2023 (the "Warrant Modifications"). Each 2023 Warrant and ech 2023 Broker Warrant was originally exercisable to acquire one common share of the Company for a period of five years from the date of issuance (subject to acceleration), at an exercise price of
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its
On behalf of the Board of Directors:
Paul Duffy, Executive Chairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
How much did AIMLF raise in its April 2025 private placement?
What are the terms of AIMLF's April 2025 private placement warrants?
How many units did AIMLF insiders purchase in the April 2025 placement?
What changes were made to AIMLF's June 2023 warrants?
